1 |
van de Sand L, Braß P, Gregorius J, Pattberg K, Engler A, Dittmer U, Taube C, Brock S, Berger MM, Brenner T, Witzke O, Krawczyk A. Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients. J Clin Med 2022;12. [PMID: 36615083 DOI: 10.3390/jcm12010283] [Reference Citation Analysis]
|
2 |
Mendes GMM, Do Nascimento IJB, Marazzi-Diniz PH, Da Silveira IB, Itaborahy MF, Viana LE, Silva FA, Santana MF, Pinto RA, Dutra BG, Lacerda MVG, Araujo SA, Wanderley D, Vidigal PV, Diniz PH, Verano-Braga T, Santos RA, Leite MF. The des-Arg(9)-bradykinin/B1R axis: Hepatic damage in COVID-19. Front Physiol 2022;13:1080837. [PMID: 36601349 DOI: 10.3389/fphys.2022.1080837] [Reference Citation Analysis]
|
3 |
Sun Y, Zou Y, Wang H, Cui G, Yu Z, Ren Z. Immune response induced by novel coronavirus infection. Front Cell Infect Microbiol 2022;12. [DOI: 10.3389/fcimb.2022.988604] [Reference Citation Analysis]
|
4 |
Urwyler P, Moser S, Trendelenburg M, Sendi P, Osthoff M. Targeting thromboinflammation in COVID-19 - A narrative review of the potential of C1 inhibitor to prevent disease progression. Mol Immunol 2022;150:99-113. [PMID: 36030710 DOI: 10.1016/j.molimm.2022.08.008] [Reference Citation Analysis]
|